Previous Next

2024-03-29

IL-41 in resistance to Kawasaki disease treatments

Hematology

In this study, researchers examined the importance of IL-41 in clinical parameters and treatment resistance in Kawasaki disease. A total of 93 children with the disease were included. Serum IL-41 levels were significantly increased in children resistant to Kawasaki disease treatments. Serum IL-41 levels were positively correlated with erythrocyte sedimentation rate, C-reactive protein and C-reactive protein/albumin ratio, but negatively correlated with albumin. Total number of fever days and neutrophil/lymphocyte ratio were independent predictors of resistance to intravenous immunoglobulin. 


Source(s) :
Yan Duan et al. Serum IL-41 might be a biomarker for IVIG resistance and coronary artery lesions in Kawasaki disease. Int Immunopharmacol. 2023 Sep:122:110600. ;

Last press reviews


PSMA, a revolution against prostate cancer

#ProstateCancer  #Cancer  #Prostate  #Therapy  #Inno...

HER2, the key to revolutionizing cancer treatment

#Oncology  #Cancer  #HER2  #TargetedTherapy  #Therap...

CD47: The Tumor Shield Finally Broken?

#cancer  #immunotherapy  #CD47  #innovation  ...